ERBA Diagnostics (ERBA) Short Interest Ratio & Short Volume

$0.04

0.00 (0.00%)

(As of 08/27/2020)

Stock Analysis

ERBA Diagnostics Short Interest Data

Short Selling ERBA Diagnostics ?

Sign up to receive the latest short interest report for ERBA Diagnostics and its competitors with MarketBeat's FREE newsletter.

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/14/2020	300 shares	$42.00	No Change	N/A	0	$0.14
7/31/2020	300 shares	$59.70	No Change	N/A	3	$0.20
7/15/2020	300 shares	$59.70	No Change	N/A	0.1	$0.20
6/30/2020	300 shares	$59.70	No Change	N/A	0.1	$0.20
6/15/2020	300 shares	$55.50	No Change	N/A	0.1	$0.19
5/29/2020	300 shares	$54.00	No Change	N/A	0.2	$0.18
5/15/2020	300 shares	$54.00	No Change	N/A	0.1	$0.18
4/30/2020	300 shares	$52.50	No Change	N/A	0	$0.18
4/15/2020	300 shares	$40.80	No Change	N/A	0.4	$0.14
3/31/2020	300 shares	$43.50	No Change	N/A	0	$0.15
3/13/2020	300 shares	$78.00	No Change	N/A	0.1	$0.26
2/28/2020	300 shares	$92.97	No Change	N/A	0.1	$0.31
2/14/2020	300 shares	$81.00	No Change	N/A	0	$0.27
1/31/2020	300 shares	$75.30	No Change	N/A	0	$0.25
1/15/2020	300 shares	$45.00	No Change	N/A	0	$0.15
12/31/2019	300 shares	$31.80	No Change	N/A	0	$0.11

What is ERBA Diagnostics' current short interest?: Short interest is the volume of ERBA Diagnostics shares that have been sold short but have not yet been covered or closed out. As of August 14th, traders have sold 300 shares of ERBA short. Learn More on ERBA Diagnostics' current short interest.
How does ERBA Diagnostics' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ERBA Diagnostics: Abliva AB (publ) (0.00%), Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), IMV Inc. (1.31%), Mainz Biomed (2.34%), and
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.88 billion), Tesla, Inc. ($4.06 billion), Aon plc ($3.14 billion), The Clorox Company ($2.93 billion), The Charles Schwab Co. ($2.69 billion), Moderna, Inc. ($2.19 billion), The Kroger Co. ($2.09 billion), Simon Property Group, Inc. ($1.87 billion), International Flavors & Fragrances Inc. ($1.71 billion), and Iron Mountain Incorporated ($1.64 billion). View all of the most shorted stocks.

What does it mean to sell short ERBA Diagnostics stock?: Short selling ERBA is an investing strategy that aims to generate trading profit from ERBA Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against ERBA Diagnostics?: A short squeeze for ERBA Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERBA, which in turn drives the price of the stock up even further.
How often is ERBA Diagnostics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERBA, twice per month. The most recent reporting period available is August, 14 2020.

Related Companies:

Short Interest Tools:

This page (OTCMKTS:ERBA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners